A semi-automated method for the determination of glycosylated haemoglobin.
A new routine, automated method for the determination of glycosylated haemoglobin is presented. The method offers improvements in analytical capacity, and precision, together with reduced running costs over existing methods, which should assist in making the determination of glycosylated haemoglobin more readily available to the clinician treating diabetes.
D001322:Autoanalysis; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy; D006027:Glycosides / Q000032:analysis; D006441:Hemoglobin A / Q000031:analogs & derivatives* / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use
D006027:Glycosides; D007004:Hypoglycemic Agents; D007328:Insulin; D006441:Hemoglobin A